Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-5.76%||11.13||0.7%||$778.03m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.72%||187.52||1.9%||$527.63m|
|GILD||Gilead Sciences, Inc.||-0.60%||66.65||1.0%||$475.82m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.79%||529.80||2.7%||$386.12m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.11%||179.83||2.0%||$331.72m|
|TXG||10X Genomics, Inc.||2.16%||201.41||0.0%||$178.72m|
|EXAS||EXACT Sciences Corp.||2.37%||130.97||18.1%||$176.05m|
|BNGO||Bionano Genomics, Inc.||1.68%||7.25||0.0%||$156.12m|
X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Boston, MA.